Angina - Nursing Case Study

Pathophysiology

• Primary mechanism: Angina is primarily caused by reduced blood flow to the heart muscle due to coronary artery narrowing, often from atherosclerosis. This narrowing limits oxygen delivery, especially during increased demand, causing ischemic pain.

• Secondary mechanism: Endothelial dysfunction in coronary arteries contributes by impairing vasodilation, further restricting blood flow and exacerbating oxygen supply-demand mismatch during physical activity or stress.

• Key complication: If untreated, prolonged ischemia can lead to myocardial infarction, where heart tissue is damaged or dies due to sustained lack of oxygen, significantly increasing morbidity and mortality risks.

Patient Profile

Demographics:

55-year-old male, office manager

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia

• Current medications: Metoprolol, Metformin, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain and shortness of breath

• Key symptoms: Pressure-like chest pain radiating to the left arm, nausea, sweating, fatigue

• Vital signs: Blood pressure 150/95 mmHg, Heart rate 110 bpm, Respiratory rate 22 breaths per minute, Temperature 98.6°F, Oxygen saturation 93% on room air

Section 1

As the patient is admitted to the emergency department, the initial assessment reveals worsening chest pain and increasing shortness of breath despite rest. The chest pain remains pressure-like and continues to radiate to the left arm. His vital signs indicate persistent hypertension with a blood pressure of 155/98 mmHg, and tachycardia with a heart rate of 115 bpm. Oxygen saturation has decreased further to 90% on room air, indicating compromised respiratory function. An ECG is performed, showing ST-segment depression, which is suggestive of myocardial ischemia, reinforcing the suspicion of unstable angina. The patient is placed on supplemental oxygen, and nitroglycerin is administered to alleviate the chest pain and improve coronary blood flow.

While awaiting lab results, including cardiac biomarkers like troponins and a complete blood count, the patient begins to exhibit signs of increased anxiety and restlessness. His skin is cool and clammy to the touch, which may indicate insufficient tissue perfusion. These symptoms, coupled with his medical history of hypertension, Type 2 Diabetes, and hyperlipidemia, heighten the concern for a potential progression to an acute coronary syndrome. The nursing team must closely monitor the patient's hemodynamic status and be prepared for rapid intervention if his condition deteriorates further.

In light of these findings, the clinical team decides to escalate care by consulting cardiology for possible coronary angiography, given the risk of significant coronary artery obstruction. This step is crucial to determine the extent of coronary artery disease and to guide further intervention, such as angioplasty or stent placement. The unfolding situation requires vigilant monitoring, timely clinical reasoning to interpret evolving symptoms, and a proactive approach to prevent the transition from unstable angina to myocardial infarction.

Section 2

As the emergency department team continues to monitor the patient, new diagnostic results from the laboratory arrive, providing critical information that further informs the clinical decision-making process. The cardiac biomarkers reveal elevated troponin levels, suggesting myocardial injury and confirming the transition from unstable angina to a non-ST elevation myocardial infarction (NSTEMI). Concurrently, the complete blood count shows a mild leukocytosis, which may indicate a stress response or underlying inflammation. These findings necessitate an urgent reassessment of the patient's management plan to mitigate further cardiac damage.

In response to the deteriorating condition, the clinical team intensifies the pharmacological treatment. Aspirin and a P2Y12 inhibitor are promptly administered to inhibit platelet aggregation and reduce the risk of further thrombus formation. A beta-blocker is considered to manage tachycardia and reduce myocardial oxygen demand, but the patient's hypotensive tendencies and cool, clammy skin require careful titration of such medications. The nursing staff diligently monitors the patient for any signs of bleeding, given the increased risk associated with antiplatelet therapy, and continuously assesses vital signs and oxygen saturation to ensure stability.

While the cardiology consult sets the stage for expedited coronary angiography, the nursing team remains vigilant for any new complications, such as arrhythmias or heart failure, which could arise due to the evolving myocardial ischemia. The patient's escalating anxiety is addressed with a supportive approach, ensuring both physical and emotional comfort. As the patient's journey progresses, the integration of clinical reasoning with prompt intervention continues to be vital in preventing further cardiac compromise and guiding the patient towards recovery.

Section 3

As the patient undergoes expedited coronary angiography, the procedure reveals a significant stenosis in the left anterior descending artery, necessitating urgent percutaneous coronary intervention (PCI). However, shortly after the angiography, the nursing team observes a change in the patient's status. The patient begins to complain of increased shortness of breath, and upon examination, the respiratory rate is elevated at 28 breaths per minute. Auscultation of the lungs reveals crackles at the bases, and the oxygen saturation has decreased to 90% on room air.

These findings suggest the development of acute heart failure, likely precipitated by the myocardial injury and increased cardiac workload. The nursing staff promptly initiates supplemental oxygen to improve the patient's oxygenation, while the medical team considers diuretic therapy to alleviate pulmonary congestion. The patient's blood pressure is noted at 88/56 mmHg, indicating a need for careful fluid management to avoid exacerbating hypotension.

A repeat assessment of cardiac biomarkers is ordered to evaluate ongoing myocardial stress, and an echocardiogram is scheduled to assess the heart's ejection fraction and overall function. The clinical team discusses the possibility of initiating an ACE inhibitor to support cardiac function and reduce afterload, while closely monitoring renal function and hemodynamic status. As the healthcare providers navigate these new complications, they continue to emphasize a multidisciplinary approach, involving cardiology, nursing, and pharmacy teams to optimize the patient’s management and prevent further deterioration.

Section 4

As the multidisciplinary team continues to manage the patient's acute heart failure, the initial response to supplemental oxygen shows some improvement in oxygen saturation, which now reads at 94% with 2 liters of oxygen via nasal cannula. However, the patient's respiratory distress persists, and crackles remain audible upon auscultation. The team decides to initiate intravenous furosemide to address the pulmonary congestion, closely monitoring the patient's blood pressure due to the existing hypotension.

Shortly after the administration of diuretics, the patient's urine output increases, and there is a slight improvement in respiratory symptoms, although the blood pressure remains borderline at 90/58 mmHg. The repeat assessment of cardiac biomarkers reveals an elevated troponin level, indicating ongoing myocardial injury. The echocardiogram results show a reduced ejection fraction of 35%, confirming significant left ventricular dysfunction.

In response to these findings, the medical team deliberates the cautious initiation of a low-dose ACE inhibitor to improve cardiac output and reduce afterload while ensuring that renal function and electrolytes are closely monitored. Nursing staff are vigilant in assessing the patient's fluid status, blood pressure, and electrolyte balance. The continuation of a collaborative approach among cardiology, nursing, and pharmacy teams emphasizes the importance of precise medication adjustments and vigilant monitoring to stabilize the patient's condition and prevent further complications such as cardiogenic shock.

Section 5

As the patient's management continues, the clinical team notices a change in the patient's status that warrants immediate attention. Approximately two hours after initiating the low-dose ACE inhibitor, the patient begins to exhibit signs of increased respiratory distress, with an oxygen saturation dropping to 89% despite being on supplemental oxygen. The nursing staff promptly perform a respiratory assessment, revealing an increase in the intensity of crackles upon auscultation bilaterally, and the patient appears more diaphoretic and anxious. The blood pressure has further decreased to 85/52 mmHg, raising concerns about potential worsening of the patient's hemodynamic status.

In addition to these respiratory concerns, the patient starts to complain of new onset chest pain, described as a pressure-like sensation radiating to the left arm. Given the elevated troponin levels previously noted, these symptoms suggest a possible exacerbation of myocardial ischemia. The medical team quickly coordinates a repeat ECG, which shows new ST-segment changes consistent with ischemia. The team discusses the possibility of acute coronary syndrome and considers the need for urgent coronary intervention, while also reassessing the patient's medication regimen to ensure it is optimized for both heart failure and ischemic management without further compromising blood pressure.

The multidisciplinary team collaborates to adjust the treatment plan, considering the delicate balance between alleviating pulmonary congestion and avoiding further hypotension. They discuss the potential need for inotropic support to improve cardiac contractility and perfusion if the patient's condition continues to deteriorate. As clinical reasoning shifts towards preventing cardiogenic shock, the team remains vigilant in their monitoring, with nurses providing minute-to-minute assessments of vital signs and fluid balance, ensuring any subtle changes are promptly communicated and addressed. This critical juncture in the patient's care underscores the complexity of managing concurrent cardiac and respiratory complications, highlighting the necessity for precise, coordinated intervention.